Vor Biopharma Cash Flow Statement
NASDAQ: VORHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
19.90+0.77 (+4.03%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Vor Biopharma free cash flow
In fiscal 2025, Vor Biopharma generated -$142.7 million of operating cash flow and spent $941,000 on capital expenditures. That left free cash flow of -$143.7 million.
Summary generated from market data by MetaCap's automated system. Methodology
Vor Biopharma cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 |
|---|---|---|---|---|---|---|
| Net Income | -695.98M | -116.91M | -117.86M | -92.09M | -68.90M | -43.34M |
| Net Income growth (YoY) | — | — | — | — | — | — |
| Depreciation & Amortization | 2.89M | 3.53M | 3.49M | 2.52M | 1.43M | 605.00K |
| Stock-Based Compensation | 18.91M | 9.85M | 13.36M | 10.70M | 4.32M | 1.34M |
| Change in Working Capital | 10.93M | 4.67M | 963.00K | 393.00K | -263.00K | 3.32M |
| Operating Cash Flow | -142.71M | -99.66M | -100.29M | -85.14M | -69.14M | -36.29M |
| Capital Expenditures | -941.00K | -229.00K | -1.07M | -8.46M | -3.89M | -4.16M |
| Investing Cash Flow | -48.80M | 96.86M | 71.01M | -94.09M | -91.65M | -4.16M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | 503.81M | 53.39M | 2.94M | 117.14M | 232.91M | 82.53M |
| Net Change in Cash | 312.29M | 50.59M | -26.35M | -62.09M | 72.12M | 42.07M |
| Free Cash Flow | -143.65M | -99.89M | -101.36M | -93.61M | -73.04M | -40.45M |
This table shows 6 annual periods of Vor Biopharma's cash flow statement, from FY 2025 back to FY 2020, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow VOR's reporting calendar. What is a cash flow statement?